Drug Resistance in HIV-Positive Adults During the Initial Year of Antiretroviral Treatment at Ethiopian Health Centers.

Reepalu, Anton; Arimide, Dawit A; Balcha, Taye T; Yeba, Habtamu; Zewdu, Adinew; Medstrand, Patrik; Björkman, Per

Reepalu, Anton; Arimide, Dawit A; Balcha, Taye T; Yeba, Habtamu; Zewdu, Adinew; Medstrand, Patrik; Björkman, Per.

Afiliação

Reepalu A; Clinical Infection Medicine, Department of Translational Medicine, Lund University, Malmö, Sweden.
Arimide DA; Clinical Virology, Department of Translational Medicine, Lund University, Malmö, Sweden.
Balcha TT; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Yeba H; Clinical Infection Medicine, Department of Translational Medicine, Lund University, Malmö, Sweden.
Zewdu A; Adama Public Health Research and Referral Laboratory Center, Adama, Ethiopia.
Medstrand P; Adama Public Health Research and Referral Laboratory Center, Adama, Ethiopia.
Björkman P; Clinical Virology, Department of Translational Medicine, Lund University, Malmö, Sweden.

Open Forum Infect Dis ; 8(4): ofab106, 2021 Apr.

Article em En | MEDLINE | ID: mdl-34805444

Palavras-chave

Ethiopia; HIV; drug resistance; primary health care; tuberculosis

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suécia País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google